Concepedia

Author

C. Galli

Ospedale di Livorno

Also Known As

C Galli, C M ZIVKOVICH GALLI, C. Galli, Costanza Galli

23

Publications

431

Citations

8

H-Index

18

Concepts

All Affiliations

Ospedale di LivornoUniversity of PisaOspedale Santa ChiaraIstituto Oncologico Veneto
CG

About

C. Galli is an author at Ospedale di Livorno specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

99

2

Pharmacology

3

3

71

3

Gastroenterology

1

1

28

4

Neurology

1

1

41

5

Pathology

1

1

14

C. Galli

×

8

Publications

418

Citations

8

H-Index

YearCitations

Hypersensitivity reactions related to oxaliplatin (OHP)

Giovanni Brandi, Maria A. Pantaleo, C. Galli,

British Journal of Cancer

2003

138

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Andrea Fontana, Luca Galli, Anna Fioravanti,

Clinical Cancer Research

2009

88

Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.

Fable Zustovich, Lorenza Landi, Giuseppe Lombardi,

PubMed

2013

69

Temozolomide as First-Line Agent in Treating High-Grade Gliomas: Phase II Study

Salvatore Chibbaro, L. Benvenuti, A. Caprio,

Journal of Neuro-Oncology

2004

41

Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)

Francesco Di Costanzo, Alberto Sobrero, Silvia Gasperoni,

Annals of Oncology

2003

28

Sorafenib plus daily low dose temozolomide for relapsed glioblastoma: A phase II study.

Fable Zustovich, Lorenza Landi, Gaetano Lombardi,

Journal of Clinical Oncology

2011

24

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

Alfredo Falcone, Giacomo Allegrini, Monica Lencioni,

Cancer Chemotherapy and Pharmacology

1999

16

Suramin in Combination with 5-Fluorouracil (5-FU) and Leucovorin (LV) in Metastatic Colorectal Cancer Patients Resistant to 5-FU+LV-Based Chemotherapy

Alfredo Falcone, E. Pfanner, I. Brunetti,

Tumori Journal

1998

14

Page 1